Cypress Capital Management LLC (Wy) Brainstorm Cell Therapeutics Inc. Transaction History

Cypress Capital Management LLC (Wy)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$0.15 - $0.4 $1,050 - $2,800	7,000 Added 233.33%	10,000 $2,000
Q3 2023 Nov 13, 2023	BUY	$0.2 - $2.08 $400 - $4,160	2,000 Added 200.0%	3,000 $0
Q2 2023 Aug 01, 2023	BUY	$2.0 - $3.2 $2,000 - $3,200	1,000 New	1,000 $2,000
Q3 2022 Nov 14, 2022	BUY	$2.55 - $4.42 $38,250 - $66,300	15,000 Added 1500.0%	16,000 $71,000
Q2 2022 Aug 01, 2022	BUY	$2.71 - $3.6 $2,710 - $3,600	1,000 New	1,000 $3,000
Q1 2022 May 09, 2022	SELL	$2.92 - $4.19 $4,380 - $6,285	-1,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.81 - $4.23 $4,215 - $6,345	1,500 New	1,500 $6,000
Q3 2021 Nov 04, 2021	SELL	$3.14 - $4.09 $3,140 - $4,090	-1,000 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$3.99 - $17.73 $1,995 - $8,865	500 Added 100.0%	1,000 $5,000
Q2 2020 Aug 11, 2020	BUY	$4.42 - $12.66 $2,210 - $6,330	500 New	500 $6,000

10.5M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $74.1M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.